Analysts expect Crinetics Pharmaceuticals, Inc. to report revenue of 20.88 M for Q3 26, against a range of 19.10 M to 22.65 M. The most recent reported quarter, Q2 26, came in at 25.12 M, a 74.4% beat against the 14.40 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 361,000.00 | 1.03 M | 143,000.00 | 6.16 M | 10.73 M | 25.12 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 241,982.77 | 836,091.01 | 148,339.61 | 658,146.29 | 455,989.63 | 5.13 M | 9.74 M | 15.09 M | 22.65 M | 32.78 M | 29.09 M | 45.05 M | 42.51 M | 51.18 M | 100.90 M | 112.48 M | ||||||||||
| Low Estimate | 217,415.09 | 686,535.59 | 139,577.15 | 619,087.21 | 427,266.15 | 4.26 M | 7.99 M | 13.72 M | 19.10 M | 30.20 M | 25.76 M | 40.06 M | 39.83 M | 47.90 M | 93.63 M | 99.06 M | ||||||||||
| Consensus Estimate | 229,698.93 | 761,313.30 | 143,958.38 | 638,616.75 | 441,627.89 | 4.70 M | 8.86 M | 14.40 M | 20.88 M | 31.49 M | 27.43 M | 42.55 M | 41.17 M | 49.54 M | 97.26 M | 105.77 M |
Analysts expect Crinetics Pharmaceuticals, Inc. to report earnings per share of -1.16 for Q3 26, against a range of -1.23 to -1.09. The most recent reported quarter, Q2 26, came in at -1.14, a 7.3% beat against the -1.23 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.96 | -0.88 | -1.04 | -1.23 | -1.38 | -1.29 | -1.23 | -1.14 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.80 | -0.78 | -0.88 | -1.09 | -1.11 | -1.31 | -1.07 | -1.16 | -1.09 | -1.05 | -1.00 | -0.89 | -0.93 | -0.92 | -0.55 | -0.37 | ||||||||||
| Low Estimate | -0.94 | -0.88 | -1.04 | -1.23 | -1.23 | -1.57 | -1.31 | -1.30 | -1.23 | -1.27 | -1.16 | -0.97 | -1.09 | -1.04 | -0.61 | -0.45 | ||||||||||
| Consensus Estimate | -0.87 | -0.83 | -0.96 | -1.16 | -1.17 | -1.44 | -1.19 | -1.23 | -1.16 | -1.16 | -1.08 | -0.93 | -1.01 | -0.98 | -0.58 | -0.41 |
Pull Wall Street consensus for Crinetics Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CRNX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CRNX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CRNX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();